Severe combined immunodeficiency pig as an emerging animal model for human diseases and regenerative medicines

키워드

참고문헌 (83)

1. Tasher D, "The genetic basis of severe combined immunodeficiency and its variants", Appl Clin Genet, 5, pp.67~80 (2012)
2. Powell EJ, "SCID pigs : An emerging large animal NK model", J Rare Dis Res Treat, 2, pp.1~6 (2017)
3. Buckley RH, "Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution", Annu Rev Immunol, 22, pp.625~655 (2004)
4. Cossu F, "Genetics of SCID", Ital J Pediatr, 36, pp.76~ (2010)
5. Macchi P, "Mutations of Jak-3gene in patients with autosomal severe combined immune deficiency(SCID)", Nature, 377, pp.65~68 (1995)
6. Noguchi M, "Interleukin-2receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans", Cell, 73, pp.147~157 (1993)
7. Russell SM, "Mutation of Jak3 in a patient with SCID : essential role of Jak3 in lymphoid development", Science, 270, pp.797~800 (1995)
8. Takeshita T, "Cloning of the gamma chain of the human IL-2 receptor", Science, 257, pp.379~382 (1992)
9. Kondo M, "Sharing of the interleukin-2(IL-2)receptor gamma chain between receptors for IL-2 and IL-4", Science, 262, pp.1874~1877 (1993)
10. Noguchi M, "Interleukin-2 receptor gamma chain : a functional component of the interleukin-7 receptor", Science, 262, pp.1877~1880 (1993)
11. Giri JG, "Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15", EMBO J, 13, pp.2822~2830 (1994)
12. Asao H, "Cutting edge : the common gamma-chain is an indispensable subunit of the IL-21 receptor complex", J Immunol, 167, pp.1~5 (2001)
13. Colonna M, "Innate lymphoid cells : diversity, plasticity, and unique functions in immunity", Immunity, 48, pp.1104~1117 (2018)
14. Leonard WJ, "Cytokines and immunodeficiency diseases", Nat Rev Immunol, 1, pp.200~208 (2001)
15. Sugamura K, "The interleukin-2receptor gamma chain : its role in the multiple cytokine receptor complexes and T cell development in XSCID", Annu Rev Immunol, 14, pp.179~205 (1996)
16. Malek TR, "Tolerance, not immunity, crucially depends on IL-2", Nat Rev Immunol, 4, pp.665~674 (2004)
17. Ghoreschi K, "Janus kinases in immune cell signaling", Immunol Rev, 228, pp.273~287 (2009)
18. Peter HH, "NK cell function in severe combined immunodeficiency(SCID) : evidence of a common T and NK cell defect in some but not all SCID patients", J Immunol, 131, pp.2332~2339 (1983)
19. Lewis SM, "The mechanism of V(D)J joining : lessons from molecular, immunological, and comparative analyses", Adv Immunol, 56, pp.27~150 (1994)
20. Oettinger MA, "V(D)J recombination : on the cutting edge", Curr Opin Cell Biol, 11, pp.325~329 (1999)
21. Villa A, "V(D)J recombination defects in lymphocytes due to RAG mutations : severe immunodeficiency with a spectrum of clinical presentations", Blood, 97, pp.81~88 (2001)
22. de Villartay JP, "Congenital defects in V(D)J recombination", Br Med Bull, 114, pp.157~167 (2015)
23. Wiler R, "Equine severe combined immunodeficiency : a defect in V(D)J recombination and DNAdependent protein kinase activity", Proc Natl Acad Sci U S A, 92, pp.11485~11489 (1995)
24. Mombaerts P, "RAG-1-deficient mice have no mature B and T lymphocytes", Cell, 68, pp.869~877 (1992)
25. Shinkai Y, "RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement", Cell, 68, pp.855~867 (1992)
26. Menoret S, "Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases", FASEB J, 27, pp.703~711 (2013)
27. Song J, "Generation of RAG 1-and 2-deficient rabbits by embryo microinjection of TALENs", Cell Res, 23, pp.1059~1062 (2013)
28. Wang Y, "Generation of knockout rabbits using transcription activator-like effector nucleases", Cell Regen (Lond), 3, pp.3~ (2014)
29. Huang J, "RAG1", 2 knockout pigs with severe combined immunodeficiency, 2014, pp.193, 1496~1503
30. Schuetz C, "SCID patients with ARTEMIS vs RAG deficiencies following HCT : increased risk of late toxicity in ARTEMIS-deficient SCID", Blood, 123, pp.281~289 (2014)
31. Buckley RH, "Human severe combined immunodeficiency : genetic, phenotypic, and functional diversity in one hundred eight infants", J Pediatr, 130, pp.378~387 (1997)
32. Geha RS, "Primary immunodeficiency diseases : an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee", J Allergy Clin Immunol, 120, pp.776~794 (2007)
33. Winandy S, "Pre-T cell receptor(TCR)and TCR-controlled checkpoints in T cell differentiation are set by Ikaros", J Exp Med, 190, pp.1039~1048 (1999)
34. Nemazee D, "Receptor editing in lymphocyte development and central tolerance", Nat Rev Immunol, 6, pp.728~740 (2006)
35. Smith-Garvin JE, "T cell activation", Annu Rev Immunol, 27, pp.591~619 (2009)
36. Tchilian EZ, "A deletion in the gene encoding the CD45 antigen in a patient with SCID", J Immunol, 166, pp.1308~1313 (2001)
37. Otsu M, "Reconstitution of lymphoid development and function in ZAP-70-deficient mice following gene transfer into bone marrow cells", Blood, 100, pp.1248~1256 (2002)
38. Legname G, "Inducible expression of a p56Lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes", Immunity, 12, pp.537~546 (2000)
39. Goldman FD, "Defective expression of p56lck in an infant with severe combined immunodeficiency", J Clin Invest, 102, pp.421~429 (1998)
40. Hubert P, "Defective p56Lck activity in T cells from an adult patient with idiopathic CD4＋ lymphocytopenia", Int Immunol, 12, pp.449~457 (2000)
41. Rathmell JC, "Pathways of apoptosis in lymphocyte development, homeostasis, and disease", Cell, 109(Suppl), pp.97~107 (2002)
42. Hershfield MS, "Genotype is an important determinant of phenotype in adenosine deaminase deficiency", Curr Opin Immunol, 15, pp.571~577 (2003)
43. Pannicke U, "Reticular dysgenesis(aleukocytosis)is caused by mutations in the gene encoding mitochondrial adenylate kinase 2", Nat Genet, 41, pp.101~105 (2009)
44. Lagresle-Peyrou C, "Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness", Nat Genet, 41, pp.106~111 (2009)
45. Noma T, "Dynamics of nucleotide metabolism as a supporter of life phenomena", J Med Invest, 52, pp.127~136 (2005)
46. Panayiotou C, "The characterization of human adenylate kinases 7 and 8 demonstrates differences in kinetic parameters and structural organization among the family of adenylate kinase isoenzymes", Biochem J, 433, pp.527~534 (2011)
47. Yagi H, "Defect of thymocyte emigration in a T cell deficiency strain(CTS)of the mouse", J Immunol, 157, pp.3412~3419 (1996)
48. Shiow LR, "The actin regulator coronin 1A is mutant in a thymic egressdeficient mouse strain and in a patient with severe combined immunodeficiency", Nat Immunol, 9, pp.1307~1315 (2008)
49. Mueller P, "Regulation of T cell survival through coronin-1-mediated generation of inositol-1, 4, 5-trisphosphate and calcium mobilization after T cell receptor triggering", Nat Immunol, 9, pp.424~431 (2008)
50. Haraldsson MK, "The lupus-related Lmb3 locus contains a diseasesuppressing Coronin-1A gene mutation", Immunity, 28, pp.40~51 (2008)
51. Shiow LR, "Severe combined immunodeficiency(SCID)and attention deficit hyperactivity disorder(ADHD)associated with a Coronin-1A mutation and a chromosome 16p11. 2 deletion", Clin Immunol, 131, pp.24~30 (2009)
52. Moshous D, "Wholeexome sequencing identifies Coronin-1A deficiency in 3siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation", J Allergy Clin Immunol, 131, pp.1594~1603 (2013)
53. Mace EM, "Lytic immune synapse function requires filamentous actin deconstruction by Coronin 1A", Proc Natl Acad Sci U S A, 111, pp.6708~6713 (2014)
54. McKusick VA, "Dwarfism in the amish. Ii. cartilage-hair hypoplasia", Bull Johns Hopkins Hosp, 116, pp.285~326 (1965)
55. Thiel CT, "The molecular basis of the cartilage-hair hypoplasia-anauxetic dysplasia spectrum", Best Pract Res Clin Endocrinol Metab, 25, pp.131~142 (2011)
56. Ryu J, "Use of gene-editing technology to introduce targeted modifications in pigs", J Anim Sci Biotechnol, 9, pp.5~ (2018)
57. Gaj T, "ZFN, TALEN, and CRISPR", Cas-based methods for genome engineering, 2013, pp.31, 397~405
58. Doyon Y, "Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases", Nat Biotechnol, 26, pp.702~708 (2008)
59. Meyer M, "Gene targeting by homologous recombination in mouse zygotes mediated by zinc-finger nucleases", Proc Natl Acad Sci U S A, 107, pp.15022~15026 (2010)
60. Geurts AM, "Knockout rats via embryo microinjection of zinc-finger nucleases", Science, 325, pp.433~ (2009)
61. Zschemisch NH, "Zinc-finger nuclease mediated disruption of Rag1 in the LEW", Ztm rat, 2012, pp.13, 60~
62. Hauschild J, "Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases", Proc Natl Acad Sci U S A, 108, pp.12013~12017 (2011)
63. Yang D, "Generation of PPARgamma mono-allelic knockout pigs via zinc-finger nucleases and nuclear transfer cloning", Cell Res, 21, pp.979~982 (2011)
64. Lutz AJ, "Double knockout pigs deficient in N-glycolylneuraminic acid and galactose alpha-1, 3-galactose reduce the humoral barrier to xenotransplantation", Xenotransplantation, 20, pp.27~35 (2013)
65. Whyte JJ, "Gene targeting with zinc finger nucleases to produce cloned eGFP knockout pigs", Mol Reprod Dev, 78, pp.2~ (2011)
66. Cermak T, "Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting", Nucleic Acids Res, 39, pp.e82~ (2011)
67. Hendriks WT, "TALEN-and CRISPR", Cas9-mediated gene editing in human pluripotent stem cells using lipid-based transfection, 2015, pp.34(5B), 31~25
68. Hockemeyer D, "Genetic engineering of human pluripotent cells using TALE nucleases", Nat Biotechnol, 29, pp.731~734 (2011)
69. Choi YJ, "Recombination activating gene-2(null)severe combined immunodeficient pigs and mice engraft human induced pluripotent stem cells differently", Oncotarget, 8, pp.69398~69407 (2017)
70. Jinek M, "A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity", Science, 337, pp.816~821 (2012)
71. Cong L, "Multiplex genome engineering using CRISPR", Cas systems, 2013, pp.339, 819~823
72. Hai T, "One-step generation of knockout pigs by zygote injection of CRISPR", Cas system, 2014, pp.24, 372~375
73. Whitworth KM, "Use of the CRISPR", Cas9 system to produce genetically engineered pigs from in vitro-derived oocytes and embryos, 2014, pp.91, 78~
74. Niu D, "Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9", Science, 357, pp.1303~1307 (2017)
75. Suzuki S, "Il2rg genetargeted severe combined immunodeficiency pigs", Cell Stem Cell, 10, pp.753~758 (2012)
76. Bauer TR Jr, "Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems", ILAR J, 50, pp.168~186 (2009)
77. Watanabe M, "Generation of interleukin-2 receptor gamma gene knockout pigs from somatic cells genetically modified by zinc finger nuclease-encoding mRNA", PLoS One, 8, pp.e76478~ (2013)
78. Kang JT, "Biallelic modification of IL2RG leads to severe combined immunodeficiency in pigs", Reprod Biol Endocrinol, 14, pp.74~ (2016)
79. Lee K, "Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency", Proc Natl Acad Sci U S A, 111, pp.7260~7265 (2014)
80. Dawson HD, "Structural and functional annotation of the porcine immunome", BMC Genomics, 14, pp.332~ (2013)
81. Meurens F, "The pig : a model for human infectious diseases", Trends Microbiol, 20, pp.50~57 (2012)
82. Ito R, "Current advances in humanized mouse models", Cell Mol Immunol, 9, pp.208~214 (2012)
83. Ito T, "Generation of recombination activating gene-1-deficient neonatal piglets : a model of T and B cell deficient severe combined immune deficiency", PLoS One, 9, pp.e113833~ (2014)

관련 논문AI추천